Brief Report: circRUNX1 as Potential Biomarker for Cancer Recurrence in EGFR Mutation-Positive Surgically Resected NSCLC

Authors: Carlos Pedraz-Valdunciel, PhD, Masaoki Ito, MD, Stavros Giannoukakos, PhD student, Ana Giménez-Capitán, MSc, Miguel Ángel Molina-Vila, PhD, Rafael Rosell, MD, PhD

Source: JTO Clinical and Research Reports, Vol 4, Iss 12, Pp 100604- (2023)

Subject Terms: CircRUNX1, Biomarker, EGFR mutation, NSCLC, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666364323001479; https://doaj.org/toc/2666-3643

Access URL: https://doaj.org/article/d9bf3f77370d44da9f2f5fc06d7d9205

BRCA1 Expression and Outcome in Patients With EGFR-Mutant NSCLC Treated With Gefitinib Alone or in Combination With Olaparib

Authors: Niki Karachaliou, MD, PhD, Oscar Arrieta, MD, Ana Giménez-Capitán, BSc, Erika Aldeguer, BSc, Ana Drozdowskyj, PhD, Imane Chaib, PhD, Noemí Reguart, MD, PhD, Rosario Garcia-Campelo, MD, Jing-Hua Chen, MD, Miguel Angel Molina-Vila, PhD, Rafael Rosell, MD, PhD

Source: JTO Clinical and Research Reports, Vol 2, Iss 3, Pp 100113- (2021)

Subject Terms: EGFR, Lung cancer, Gefitinib, Olaparib, GOAL study, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666364320301594; https://doaj.org/toc/2666-3643

Access URL: https://doaj.org/article/08a2152e29af4e089606394482732718

Src-Homology 2 Domain-Containing Phosphatase 2 in Resected EGFR Mutation-Positive Lung Adenocarcinoma

Authors: Masaoki Ito, MD, Jordi Codony-Servat, PhD, Ana Giménez-Capitán, BSc, Mireia Serra-Mitjans, MD, Francisco Pérez-Ochoa, MD, David Llige, BSc, Imane Chaib, PhD, Ramón Rami-Porta, MD, Carme Obiols, MD, Sergi Call, MD, Manuela Iglesias, MD, José Belda-Sanchis, MD, Xavier Tarroch-Sarasa, MD, Niki Karachaliou, MD, Miguel Angel Molina-Vila, PhD, Morihito Okada, MD, Rafael Rosell, MD

Source: JTO Clinical and Research Reports, Vol 1, Iss 4, Pp 100084- (2020)

Subject Terms: Lung adenocarcinoma, EGFR, SHP2, Surgery, Recurrence, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666364320301077; https://doaj.org/toc/2666-3643

Access URL: https://doaj.org/article/ba1595860e4f4a8a8b44fa1c6caeb13a